DekaBank Deutsche Girozentrale - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 108 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$174,000
-39.8%
31,900
+10.0%
0.00%
-100.0%
Q4 2021$289,000
-41.0%
29,000
+2.8%
0.00%0.0%
Q3 2021$490,000
-25.6%
28,2000.0%0.00%
-50.0%
Q2 2021$659,000
-6.3%
28,2000.0%0.00%0.0%
Q1 2021$703,000
+238.0%
28,2000.0%0.00%
+100.0%
Q4 2020$208,000
+48.6%
28,2000.0%0.00%0.0%
Q3 2020$140,000
-69.4%
28,200
-2.8%
0.00%
-66.7%
Q4 2018$457,00029,0000.00%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Abbot Financial Management, Inc. 1,411,775$25,243,00011.48%
Flagship Pioneering Inc. 38,506,526$688,497,0007.21%
Artal Group S.A. 4,155,625$74,303,0001.66%
HARBOURVEST PARTNERS LLC 986,878$17,645,0001.66%
Nan Fung Group Holdings Ltd 56,768$1,015,0000.32%
Lombard Odier Asset Management (Switzerland) SA 245,013$4,381,0000.27%
Bellwether Advisors, LLC 29,383$525,0000.18%
PDT Partners, LLC 65,991$1,180,0000.08%
Virtus ETF Advisers LLC 7,478$134,0000.06%
HITE Hedge Asset Management LLC 24,911$445,0000.06%
View complete list of RUBIUS THERAPEUTICS INC shareholders